Back to Search Start Over

Nuclear receptor corepressor 1 controls regulatory T cell subset differentiation and effector function.

Authors :
Stolz V
de Freitas E Silva R
Rica R
Zhu C
Preglej T
Hamminger P
Hainberger D
Alteneder M
Müller L
Waldherr M
Waltenberger D
Hladik A
Agerer B
Schuster M
Frey T
Krausgruber T
Knapp S
Campbell C
Schmetterer K
Trauner M
Bergthaler A
Bock C
Boucheron N
Ellmeier W
Source :
ELife [Elife] 2024 Oct 28; Vol. 13. Date of Electronic Publication: 2024 Oct 28.
Publication Year :
2024

Abstract

FOXP3 <superscript>+</superscript> regulatory T cells (Treg cells) are key for immune homeostasis. Here, we reveal that nuclear receptor corepressor 1 (NCOR1) controls naïve and effector Treg cell states. Upon NCOR1 deletion in T cells, effector Treg cell frequencies were elevated in mice and in in vitro-generated human Treg cells. NCOR1-deficient Treg cells failed to protect mice from severe weight loss and intestinal inflammation associated with CD4 <superscript>+</superscript> T cell transfer colitis, indicating impaired suppressive function. NCOR1 controls the transcriptional integrity of Treg cells, since effector gene signatures were already upregulated in naïve NCOR1-deficient Treg cells while effector NCOR1-deficient Treg cells failed to repress genes associated with naïve Treg cells. Moreover, genes related to cholesterol homeostasis including targets of liver X receptor (LXR) were dysregulated in NCOR1-deficient Treg cells. However, genetic ablation of LXRβ in T cells did not revert the effects of NCOR1 deficiency, indicating that NCOR1 controls naïve and effector Treg cell subset composition independent from its ability to repress LXRβ-induced gene expression. Thus, our study reveals that NCOR1 maintains naïve and effector Treg cell states via regulating their transcriptional integrity. We also reveal a critical role for this epigenetic regulator in supporting the suppressive functions of Treg cells in vivo.<br />Competing Interests: VS, Rd, RR, CZ, TP, PH, DH, MA, LM, MW, DW, AH, BA, MS, TF, TK, SK, CC, KS, MT, AB, CB, NB, WE No competing interests declared<br /> (© 2024, Stolz, de Freitas e Silva et al.)

Details

Language :
English
ISSN :
2050-084X
Volume :
13
Database :
MEDLINE
Journal :
ELife
Publication Type :
Academic Journal
Accession number :
39466314
Full Text :
https://doi.org/10.7554/eLife.78738